Thursday, March 29, 2018

BRIEF-Shire ‍says EMA has validated its marketing authorization application for Lanadelumab

* ‍ANNOUNCED EUROPEAN MEDICINES AGENCY HAS VALIDATED ITS MARKETING AUTHORIZATION APPLICATION FOR LANADELUMAB (SHP643)​
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)